期刊文献+

慢性乙型病毒性肝炎患者抗病毒治疗认知和依从性调查 被引量:4

Survey on the Awareness and Compliance in Patients with Chronic Hepatitis B Receiving Antivi- ral Treatment
下载PDF
导出
摘要 【目的】探讨慢性乙型肝炎患者对抗病毒治疗的认知程度及应用抗病毒药物的依从性特点。【方法】采用用药依从性调查表,对180例应用抗病毒药物的门诊就诊慢性乙肝患者进行问卷调查,比较患者不同年龄、文化程度、经济情况、疾病认知程度的用药依从性,分析用药依从性的影响因素。【结果】81.6%的患者能认识到慢性乙型肝炎是一种必须长期治疗的疾病,32.3%的患者能明确抗病毒药物的概念,22.0%的患者知道病毒耐药的概念;调查时点前3个月、6个月、1年及以上患者平均用药依从性为70.9%、57.1%、54.7%。不规则用药的原因分析:70.2%为经济因素,40.5%为对治疗效果不满意;年龄在20~29岁、本科以下学历、经济收入较低的患者,属于治疗依从性差的高危人群。【结论】乙型肝炎患者对抗病毒治疗的认知需进一步提高,用药依从性受多种因素影响,医务人员应依据患者情况设定个体化诊疗方案,在病程中加强用药管理教育和干预。 [Objective]To explore the awareness and compliance features of chronic hepatitis B patients to antiviral treatment and drugs. [Methods] Medication compliance questionnaire was used for the survey of 180 patients with chronic hepatitis ]3 receiving antiviral treatment in clinic service. The age, education level, economic conditions, awareness of the disease and medication compliance among patients were compared. The fac- tors influencing medication compliance were analyzed. [Results] Among all patients, 81.6% of the patients were aware of chronic hepatitis B as a disease to be treated for a long period, and 32.6% of the patients were able to understand the concept of antivirus drugs, and 22.0 % of the patients knew the concept of drug resist- ance. The average medication compliance rate at 3 months, 6 months, one year and over before survey were 70.9%, 57.1% and 54.7%, respectively. The causes of irregular medication were economic factor(70.2%) and dissatisfaction to the treatment effect(40.5%). Patients who were 20-29 years old and had educational background below undergraduate and low economic income were high-risk population with poor compliance. [Conclusion] The awareness of chronic hepatitis B patients to antiviral treatment should be further improved. Medication compliance is affected by various factors. Medical staff should plan the individualization scheme of diagnosis and treatment. Medication management, education and intervention should be strengthened in the course of the disease.
出处 《医学临床研究》 CAS 2013年第8期1481-1484,共4页 Journal of Clinical Research
关键词 肝炎 乙型 慢性 治疗 认知 Hepatitis B, Chronic/TH Cognition
  • 相关文献

参考文献3

二级参考文献30

  • 1闫杰,温少芳,王丹静,吴淑玲.乙型肝炎病毒耐药专家共识[J].中华实验和临床感染病杂志(电子版),2008,2(1):90-98. 被引量:40
  • 2Chen C.-J.,Yang H. -I.,Su J.,王铮(译),陈云茹(校).血清乙型肝炎病毒DNA水平的生物学梯度与肝细胞肝癌的风险性相关[J].世界核心医学期刊文摘(胃肠病学分册),2006,2(6):1-1. 被引量:222
  • 3Hadziyannis SJ;Tassopoulos NC;Heathcote EJ.Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years,2006.
  • 4Lok AS;Lai CL;Leung N.Long-term safety of lamivudine treatment in patients with chronic hepatitis B,2003.
  • 5Dr. Loren G. Miller MD, MPH,Honghu Liu PhD,Ron D. Hays PhD,Carol E. Golin MD,C. Keith Beck MD,Steven M. Asch MD, MPH,Yingying Ma BS,Andrew H. Kaplan MD,Neil S. Wenger MD, MPH.How well do clinicians estimate patients’ adherence to combination antiretroviral therapy?[J]. Journal of General Internal Medicine . 2002 (1)
  • 6Chotiyaputta W,Peterson C,Ditah FA,Goodwin D,Lok AS.Persistence and adherence to nucleos. Journal of Hepatology . 2011
  • 7Lee M,Keeffe EB.Study of adherence comes to the treatment of chronic hepatitis B. Journal of Hepatology . 2011
  • 8Houts PS,Doak CC,Doak LG,Loscalzo MJ.The role of pictures in improving health communication: a review of research on attention,comprehension,recall,and adherence. Patient Education and Counseling . 2006
  • 9Weiss JJ,Br u N,Stivala A,Swan T,Fishbein D.Review article: adherence to medication for chronic hepatitis C - building on the model of human immunodeficiency virus antiretroviral adherence research. Alimentary Pharmacology and Therapeutics . 2009
  • 10Digestive Health Foundation.Chronic Hepatitis B (CHB) Recommendations. . 2009

共引文献54

同被引文献28

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部